I would say its a medication no longer protected by patent that Sanofi has acquired and they want to up the horse power with a rapid delivery system to make it super-charged and effectively give that medication an advantage over any other pharma that wants to take up that medication.
I would say it is a medication that when it is used, it is only used when it is seriously needed in a life and death situation so rapid onset and delivery is a competitive advantage in the application of a serious life and death medication.
Not too many Sanofi medications fit that bill. I would say.
It is a very short list. I would say.
I would say its a medication no longer protected by patent that...
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.010(8.33%) |
Mkt cap ! $136.5M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.0¢ | 12.0¢ | $133.5K | 1.063M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11996 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 367267 | 9 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
12.8¢ |
Change
0.010 ( 6.25 %) |
||||
| Open | High | Low | Volume | ||
| 12.5¢ | 13.0¢ | 12.5¢ | 582454 | ||
| Last updated 14.53pm 03/05/2024 ? | |||||
| ALA (ASX) Chart |